Aspire Healthcare Pharma (India) Private Limited - Company Profile

It is a infrastructure and utilities foreign private limited company based in Chennai, Tamil Nadu, India, established in 2019.
2019 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Aspire Healthcare Pharma (India) Private Limited

Aspire Healthcare Pharma (India) Private Limited, a active foreign private limited company, was established on 12 March 2019 in Chennai, Tamil Nadu, India. Engaging in infrastructure project management within the professional, scientific and technical sector, it holds CIN: U74999TN2019FTC127980. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Formerly known as Morningside Healthcare (India) Private Limited. Employing 54 professional, Its leadership includes Murali Raman (Director), Gary David Buckley (Director), Richard Michael Condon (Director). Past directors included Danesh Vinodkumar Gadhia, Gary David Buckley, Ian Brace. Its latest AGM occurred on 24 September 2025, with the balance sheet filed on 31 March 2025. It is based at The Executive Center, Level 5, Prestige Palladium,, Bayan No 129-140,, Chennai, Tamil Nadu, 600006.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999TN2019FTC127980

  • Registration Number

    127980

  • Incorporation Date

    12 March 2019

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 110.07%
  • Profit Growth **** 122.57%
  • Ebitda **** 282.13%
  • Net Worth 159.86%
  • Total Assets -29.48%
Company report

Aspire Healthcare Pharma (India) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aspire Healthcare Pharma (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aspire Healthcare Pharma (India) Private Limited?
Current Directors
Name Designation Appointment Date Status
Murali Raman Director 12 Mar 2019 Current
Gary David Buckley Director 26 Jul 2023 Current
Richard Michael Condon Director 06 Jan 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director - Past
Pramod Abcsdd Additional Director 26 Jul 2023 Past
Pramod Abcsdd Additional Director 25 Jul 2023 Past
Pramod Abcsdd Director 01 Oct 2022 Past
Pramod Abcsdd Additional Director 25 Jul 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aspire Healthcare Pharma (India).

Aspire Healthcare Pharma (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 110.07% increase. The company also saw a substantial improvement in profitability, with a 122.57% increase in profit. The company's net worth Soared by an impressive increase of 159.86%.

Aspire Healthcare Pharma (India) revenue growth over time
Aspire Healthcare Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 110.07%
*******
*******
*******
*******
Revenue from Operations
*******
 110.07%
*******
*******
*******
*******
Total Assets
*******
 -29.48%
*******
*******
*******
*******
Profit or Loss
*******
 122.57%
*******
*******
*******
*******
Net Worth
*******
 159.86%
*******
*******
*******
*******
EBITDA
*******
 282.13%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aspire Healthcare Pharma (India)?

In 2023, Aspire Healthcare Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Aspire Healthcare Pharma (India)?

Aspire Healthcare Pharma (India) has a workforce of 54 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aspire Healthcare Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aspire Healthcare Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aspire Healthcare Pharma (India)
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Aspire Healthcare Pharma (India) Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Aspire Healthcare Pharma (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was recorded as a recent event.

  • Director Appointment

    Gary David Buckley was appointed as a Director was appointed as a Director on 26 Jul 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.

  • Director Appointment

    The activity Richard Michael Condon was appointed as a Director was appointed as a Director on 06 Jan 2023 & has been associated with this company since 3 years 1 month . was completed.

  • Director Appointment

    Murali Raman was appointed as a Director was appointed as a Director on 12 Mar 2019 & has been associated with this company since 6 years 11 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Aspire Healthcare Pharma (India) Private Limited was registered on 12 Mar 2019 with Roc Chennai & aged 6 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Aspire Healthcare Pharma (India) Private Limited?

The CIN of Aspire Healthcare Pharma (India) Private Limited is U74999TN2019FTC127980.

Where is Aspire Healthcare Pharma (India) Private Limited headquartered?

Aspire Healthcare Pharma (India) Private Limited is headquartered at The Executive Center, Level 5, Prestige Palladium,, Bayan No 129-140,, Chennai, Tamil Nadu, 600006.

When was Aspire Healthcare Pharma (India) Private Limited incorporated?

Aspire Healthcare Pharma (India) Private Limited was incorporated on 12 March 2019.

Who are the current directors of Aspire Healthcare Pharma (India) Private Limited?

The current directors of Aspire Healthcare Pharma (India) Private Limited are

What is the primary industry of Aspire Healthcare Pharma (India) Private Limited?

The primary industry of Aspire Healthcare Pharma (India) Private Limited is Professional, Scientific And Technical.

Is Aspire Healthcare Pharma (India) Private Limited a listed company?

Aspire Healthcare Pharma (India) Private Limited is unlisted.

What is the capital structure of Aspire Healthcare Pharma (India) Private Limited?

The authorized capital of Aspire Healthcare Pharma (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available